- Home
- CDRO vs PBYI Comparison
CDRO vs PBYI Comparison
Compare CDRO & PBYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CDRO | PBYI |
|---|---|---|
| Founded | 2014 | 2010 |
| Country | Luxembourg | United States |
| Employees | 325 | N/A |
| Industry | Services-Misc. Amusement & Recreation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 363.1M | 318.0M |
| IPO Year | N/A | 2011 |
Fundamental Metrics
Financial Performance| Metric | CDRO | PBYI |
|---|---|---|
| Price | $8.35 | $6.15 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $9.00 | N/A |
| AVG Volume (30 Days) | 13.2K | ★ 313.8K |
| Earning Date | 02-28-2023 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.61 |
| Revenue | N/A | ★ $27,685,000.00 |
| Revenue This Year | $11.31 | N/A |
| Revenue Next Year | $6.75 | N/A |
| P/E Ratio | $305.95 | ★ $10.05 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.18 | $2.58 |
| 52 Week High | $8.77 | $7.68 |
Technical Indicators
Market Signals| Indicator | CDRO | PBYI |
|---|---|---|
| Relative Strength Index (RSI) | 60.13 | 46.30 |
| Support Level | $7.73 | $5.57 |
| Resistance Level | $8.69 | $6.15 |
| Average True Range (ATR) | 0.26 | 0.20 |
| MACD | 0.02 | 0.02 |
| Stochastic Oscillator | 58.42 | 42.96 |
Price Performance
Historical ComparisonAbout CDRO Codere Online Luxembourg S.A.
Codere Online Luxembourg SA is an international online casino gaming and online sports betting group focused on providing its customers with a safe and enjoyable online gaming experience. It currently operates in Spain, Mexico, Colombia, and Other countries. where it offers its users the ability to play online casino games and bet on sports events. Online casino offerings include the full portfolio of games typically available in land-based casinos, gaming halls and gambling establishments, such as slot machines, table games, and bingo. Online sports betting involves a user placing a wager on an event at some fixed odds determined by Codere Online. The company derives maximum revenue from Mexico.
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also, it is developing Alisertib, a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis, resulting in apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.